AdvaTab Advanced ODT technology provides easy ingestion for pediatric, geriatric, and dysphagic patients
- Composed of finely micronized particles rapidly disintegrating into a smooth, viscous suspension
- An easy-to-take dosage solution:
- Masks bitter drug taste
- Rapidly dissolves in the mouth without water
- AdvaTab tablets have been proven bioequivalent to immediate or sustained release formulations
Patented formulations and manufacturing process
- Advatabs® incorporate uniformly dispersed, coated drug particles in a low-moisture, rapidly disintegrating matrix
- Formulated for acceptable taste, a disintegration time <30 seconds
- Suitable for push-through blister packs and multiple-packing configurations
- Up to 500 mg drug-loading capability
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Senior Director of Drug Product Development & Site Leader at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s facilities, supporting a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.